Y群序列型1466脑膜炎奈瑟菌全州暴发——弗吉尼亚州,2022-2024年
2022年8月,弗吉尼亚州东部卫生规划区8周内发现4例确诊病例,启动暴发调查,3例临床分离株为Y群序列型1466脑膜炎奈瑟菌。全州调查发现36例遗传相关病例,截至2024年3月1日死亡7例(病死率19.4%)。多数患者(63.9%)为30-60岁、通常不被认为高危的年龄组,78.0%为非西班牙裔黑人或非裔美国人,未发现共同暴露、隶属关系或危险因素,无法确定目标人群进行疫苗接种;弗吉尼亚州卫生部推荐对部分密切接触者基于IMD危险因素和与病例相似的年龄范围接种四价(A、C、W、Y群)脑膜炎球菌结合疫苗。
要点
- 全州调查发现36例遗传相关Y群序列型1466脑膜炎奈瑟菌病例,截至2024年3月1日死亡7例,病死率19.4%。
- 63.9%的患者为30-60岁,78.0%为非西班牙裔黑人或非裔美国人,未发现共同暴露或危险因素。
- 因无法确定定义人群进行疫苗接种,弗吉尼亚州卫生部推荐对部分密切接触者基于IMD危险因素和年龄范围接种四价脑膜炎球菌结合疫苗。
核心结论
- 侵袭性脑膜炎球菌病暴发可能影响没有既定IMD危险因素的人群。
- 缺乏明确的高危人群可能促使探索新的控制策略,如选择性疫苗接种密切接触者。
研究设计与样本
- 弗吉尼亚州卫生部于2022年8月开始调查东部卫生规划区的IMD暴发,起因是8周内发现4例确诊病例。
- 对3例病例的临床分离株进行特征分析,鉴定为Y群序列型1466脑膜炎奈瑟菌。
- 随后开展全州调查,发现36例遗传相关病例,截至2024年3月1日死亡7例(病死率19.4%)。
主要发现
- 大多数患者(63.9%)年龄在30-60岁,该年龄组通常不被认为IMD风险增加。
- 78.0%的患者为非西班牙裔黑人或非裔美国人。
- 未发现共同暴露、隶属关系或危险因素,无法确定定义人群进行疫苗接种。
关键数值与推荐
- 弗吉尼亚州卫生部推荐对部分密切接触者基于IMD危险因素和与确诊病例相似的年龄范围接种四价(A、C、W、Y群)脑膜炎球菌结合疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive meningococcal disease (IMD) is a severe illness that can have devastating effects; outbreaks are uncommon in the United States. Vaccination is the preferred control measure for IMD outbreaks when a defined population at risk (e.g., college students or persons experiencing homelessness) can be identified. In August 2022, the Virginia Department of Health (VDH) began investigating an IMD outbreak in Virginia's Eastern Health Planning Region, prompted by the detection of four confirmed cases within 8 weeks. Clinical isolates available from three cases were characterized as Neisseria meningitidis serogroup Y, sequence type 1466. A subsequent statewide investigation identified 36 genetically related cases, including seven deaths (case fatality rate = 19.4%) as of March 1, 2024. A majority of patients (63.9%) were in an age group (30-60 years) not generally considered at increased risk for IMD; 78.0% were non-Hispanic Black or African American. No common exposures, affiliations, or risk factors were identified, and a defined population could not be identified for vaccination. VDH recommended quadrivalent (serogroups A, C, W, and Y) meningococcal conjugate vaccination of a subset of close contacts of patients based on IMD risk factors and age range similar to that of patients with identified cases. IMD outbreaks might affect populations without established IMD risk factors. Lack of a well-defined population at risk might prompt exploration of novel control strategies, such as selective vaccination of close contacts.
引用
- Robinson M, Crain J, Kendall B, et al. Statewide Outbreak of Neisseria meningitidis Serogroup Y, Sequence Type 1466 - Virginia, 2022-2024. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39480707. doi:10.15585/mmwr.mm7343a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。